# Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK

> **NCT01905462** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1046 (actual)

## Conditions studied

- Infections, Papillomavirus

## Interventions

- **OTHER:** Data Collection
- **BIOLOGICAL:** Cervarix

## Key facts

- **NCT ID:** NCT01905462
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 1046 (ACTUAL)
- **Last updated:** 2013-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01905462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01905462, "Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01905462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*